116
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Differential behavioral, physiological, and hormonal sensitivity to LPS challenge in rats

, , , , &
Pages 1-13 | Published online: 18 Dec 2008

References

  • Maes M. Major depression and activation of the inflammatory response system. Adv Exp Med Biol. 1999;461:25–46.
  • Sluzewska A. Indicators of immune activation in depressed patients. Adv Exp Med Biol. 1999;461:59–73.
  • Maes M. Psychological stress and the inflammatory response system. Clin Sci (Lond). 2001;101:193–194.
  • Zorrilla EP, Luborsky L, McKay JR, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain BehavImmun. 2001;15:199–226.
  • Miller GE, Rohleder N, Stetler C, Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. PsychosomMed. 2005;67:679–687.
  • Connor TJ, Leonard BE. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 1998;62:583–606.
  • Maes M, Lin AH, Delmeire L, et al. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry. 1999;45:833–839.
  • Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol. 2001;11:203–208.
  • Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O’Brien JT. Increase in interleukin-lbeta in late-life depression. Am J Psychiatry. 2005;162:175–177.
  • Pollak Y, Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol. 2002;5:389–399.
  • Hauser P, Khosla J, Aurora H, et al. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry. 2002;7:942–947.
  • Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med. 2001;344:961–966.
  • Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Ann Rev Biochem. 2002;71:635–700.
  • Vedder H, Schreiber W, Yassouridis A, Gudewill S, Galanos C, Pollmacher T. Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans. Inflamm Res. 1999;48:67–74.
  • Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology. 1993;187:403–416.
  • Ottaway CA, Fong IW, Da Silva B, Singer W, Karras L. Integrative aspects of a human model of endotoxemia. Can J Physiol Pharmacol. 1998;76:473–478.
  • Schreiber W, Pollmacher T, Fassbender K, et al. Endotoxin- and corticotropin-releasing hormone-induced release of ACTH and cortisol. A comparative study in men. Neuroendocrinology. 1993;58:123–128.
  • Reichenberg A, Yirmiya R, Schuld A, et al. Cytokine-associated emotional and cognitive disturbance in humans. Arch Gen Psychiatry. 2001;58:445–452.
  • Borowski T, Kokkinidis L, Merali Z, Anisman H. Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia. Neuroreport. 1998;9:3797–3802.
  • Fishkin RJ, Winslow JT. Endotoxin-induced reduction of social investigation by mice: interaction with amphetamine and antiinflammatory drugs. Psychopharmacology (Berl). 1997;132:335–341.
  • Shen Y, Connor TJ, Nolan Y, Kelly JP, Leonard BE. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioral symptoms in the rat. Life Sci. 1999;65:1773–1786.
  • Dantzer R. Bluthe RM, Laye S, Bret-Dibat JL, Parnet P, Kelley KW. Cyotokines and sickness behaviour. J Ann NY Acad Sci. 1998;840:586–590.
  • Quinn LP, Stean TO, Trail B, et al. LABORAS: Initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour. J Neurosci Methods. 2003;130:83–92.
  • Bluthe RM, Dantzer R, Kelley KW. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res. 1992;573:318–320.
  • Yirmiya R, Rosen H, Donchin O, Ovadia H. Behavioral effects of lipopolysaccharide in rats: involvement of endogenous opioids. Brain Res. 1994;648:80–86.
  • Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996;711:163–174.
  • Hrupka BJ, Langhans W. A role for serotonin in lipopolysac-charide-induced anorexia in rats. Pharmacol Biochem Behav. 2001;68:355–362.
  • Lugarini F, Hrupka BJ, Schwartz GJ, Plata-Salaman CR, Langhans W. A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. Am J Physiol Regul Integr Comp Physiol. 2002;283: R862-R868.
  • Aubert A, Dantzer R. The taste of sickness: lipopolysaccharide-induced finickiness in rats. Physiol Behav. 2005;84:437–444.
  • Plata-Salaman CR, Borkoski JP. Centrally administered bacterial lipopolysaccharide depresses feeding in rats. Pharmacol Biochem Behav. 1993;46:787–791.
  • Bluthe RM, Castanon N, Pousset F, et al. Central injection of IL-10 antagonizes the behavioral effects of lipopolysaccharide in rats. Psychoneuroendocrinology. 1999;24:301–311.
  • Yirmiya R, Pollak Y, Barak O, et al. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology. 2001;24:531–544.
  • Dogan MD, Ataoglu H, Akarsu ES. Effects of different serotypes of Escherichia coli lipopolysaccharides on body temperature in rats. Life Sci. 2000;67:2319–2329.
  • Dogan MD, Ataoglu H, Akarsu ES. Characterization of the hypothermic component of LPS-induced dual thermoregulatory response in rats. Pharmacol Biochem Behav. 2002;72:143–150.
  • Szekely M, Szelenyi Z. Endotoxin fever in the rat. Acta Physiol Acad Sc Hung. 1979;53:265–277.
  • Romanovsky AA, Almeida MC, Aronoff DM, et al. Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front Biosci. 2005;10:2193–2216.
  • Zuckerman SH, Shellhaas J, Butler LD. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol. 1989;19:301–305.
  • Givalois L, Dornand J, Mekaouche M, et al. Temporal cascade of plasma level surges in ACTH, corticosterone, and cytokines in endotoxin-challenged rats. Am J Physiol. 1994;267:R164–R170.
  • Takao T, Nanamiya W, Takemura T, et al. Endotoxin induced increases in rat plasma pituitary-adrenocortical hormones are better reflected by alterations in tumor necrosis factor alpha than interleukin-1beta. Life Sci. 1997;61:263–268.
  • Kakucksa L, Qi Y, Clark BD, Lechan RM. Endotoxin-induced corticotrophin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology. 1993;133:815–821.
  • Rivest S, Laflamme N, Nappi RE. Immune challenge and immobilization stress induce transcription ofthe gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J Neurosci. 1995;15:2680–2695.
  • Sagar SM, Price KJ, Kasting NW, Sharp FR. Anatomic patterns of FOS immunostaining in the rat brain following systemic endotoxin administration. Brain Res Bull. 1995;36:381–392.
  • Wan WL, Wetmore CM, Sorenson CM, Greenberg AH, Nance DM. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res Bull. 1994;34:7–14.
  • Tilders FJH, Schmidt ED, De Goelj DCE. Phenotypic plasticity of CRF neurons during stress. Ann NY Acad Sci. 1993;697:39–52.
  • Anisman H, Merali Z, Poulter MO, Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des. 2005;11:963–972.
  • Kent S, Bluthe RM, Kelley KW, Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci. 1992;13:24–28.
  • Watkins LR, Maier SF. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med. 2005;257:139–155.
  • Licinio J, Wong ML. Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest. 1997;100:2941–2947.
  • Buller KM. Role of circumventricular organs in pro-inflammatory cytokine-induced activation of the hypothalamic-pituitary-adrenal axis. Clin Exp Pharmacol Physiol. 2001;28:581–589.
  • Cao C, Matsumura K, Watanabe Y. Induction of cyclooxygenase-2 in the brain by cytokines. Ann. N Y Acad Sci. 1997;813:307–309.
  • Ek M, Kurosawa M, Lundeberg T, Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci. 1998;18:9471–9479.
  • Goehler LE, Gaykema RP, Hammack SE, Maier SF, Watkins LR. Interleukin-1 induces c-Fos immunoreactivity in primary afferent neurons of the vagus nerve. Brain Res. 1998;804:306–310.
  • Goehler LE, Gaykema RP, Nguyen KT, et al. Interleukin-lbeta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J Neurosci. 1999;19:2799–2806.
  • Dantzer R, Konsman JP, Bluthe RM, Kelley KW. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci. 2000;85:60–65.
  • Konsman JP, Luheshi GN, Bluthe RM, Dantzer R. The vagus nerve mediates behavioral depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur J Neurosci. 2000;12:4434–4446.
  • Bluthe RM, Walter V, Parnet P, et al. Lipopolysaccharide induces sickness behavior in rats by a vagal mediated mechanism. C R Acad Sci (III). 1994;317:499–503.
  • Bluthe RM, Michaud B, Kelley KW, Dantzer R. Vagotomy blocks behavioral effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. Neuroreport. 1996;7:2823–2827.
  • Lacosta S, Merali Z, Anisman H. Influence of acute and repeated interleukin-2 administration on spatial learning, locomotor activity, exploratory behaviors, and anxiety. Behav Neurosci. 1999;113:1030–1041.
  • Yirmiya R, Pollak Y, Morag M, et al. Illness, cytokines, and depression. Ann N Y Acad Sci. 2000;917:478–487.
  • Reichenberg A, Yirmiya R, Schuld A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001;58:445–452.
  • Calvano JE, Bowers DJ, Coyle SM, et al. Response to systemic endotoxemia among humans bearing polymorphisms of the Toll-like receptor 4 (hTLR4). Clin Immun. 2006;121:186–190.
  • Krabbe KS, Bruunsgaard H, Hansen CM, et al. Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immun. 2001;8:333–338.
  • Van Eijk LT, Dorresteijn MJ, Smits P, et al. Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med. 2007;35:1464–1469.